We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
-11.85%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
AUM
$2.34B
AUM Growth
-$178M
Cap. Flow
+$147M
Cap. Flow %
6.3%
Top 10 Hldgs %
62.9%
Holding
374
New
15
Increased
155
Reduced
121
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 3%
2 Healthcare 2.16%
3 Financials 1.87%
4 Consumer Staples 1.63%
5 Industrials 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
326
Warner Bros
WBD
$64.7B
$154K 0.01%
+11,460
New +$213K
HPE icon
327
Hewlett Packard
HPE
$69.4B
$137K 0.01%
10,305
-1,956
-16% -$29.7K
SPRY icon
328
ARS Pharmaceuticals
SPRY
$528M
$136K 0.01%
32,174
GORV
329
DELISTED
Lazydays
GORV
$127K 0.01%
360
CCL icon
330
Carnival Corporation Ltd
CCL
$40.5B
$106K ﹤0.01%
12,223
+2,017
+20% +$29.6K
NLY icon
331
Annaly Capital Management
NLY
$17.1B
$105K ﹤0.01%
4,456
-285
-6% -$7.38K
ROI
332
DELISTED
RiskOn International, Inc. Common Stock
ROI
$77K ﹤0.01%
+977
New +$60.7K
CFRX
333
DELISTED
ContraFect Corporation
CFRX
$46K ﹤0.01%
188
SNDL icon
334
Sundial Growers
SNDL
$315M
$36K ﹤0.01%
11,042
IBIO icon
335
iBio
IBIO
$72.5M
$33K ﹤0.01%
250
VTAK icon
336
Catheter Precision
VTAK
$996K
$24K ﹤0.01%
8
+6
+300% +$18.5K
SENS icon
337
Senseonics Holdings Inc
SENS
$282M
$22K ﹤0.01%
1,060
TTOO
338
DELISTED
T2 Biosystems, Inc
TTOO
$18K ﹤0.01%
22
AVTX icon
339
Avalo Therapeutics
AVTX
$980M
$6K ﹤0.01%
4
SINT icon
340
SiNtx Technologies
SINT
$10.6M
$6K ﹤0.01%
1
ASXC
341
DELISTED
Asensus Surgical, Inc.
ASXC
$5K ﹤0.01%
12,936
CFMS
342
DELISTED
Conformis, Inc. Common Stock
CFMS
$5K ﹤0.01%
599
SLNO
343
DELISTED
Soleno Therapeutics
SLNO
$2K ﹤0.01%
713
ACWX icon
344
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
-4,114
Closed -$215K
BAX icon
345
Baxter International
BAX
$14.7B
-2,844
Closed -$221K
BKNG icon
346
Booking.com
BKNG
$151B
-2,400
Closed -$225K
CNXC icon
347
Concentrix
CNXC
$1.56B
-2,709
Closed -$451K
CP icon
348
Canadian Pacific Kansas City
CP
$79.7B
-2,610
Closed -$215K
CSR
349
Centerspace
CSR
$917M
-2,370
Closed -$233K
DAL icon
350
Delta Air Lines
DAL
$61B
-5,687
Closed -$225K

Similar funds

Avantax Planning Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Avantax Planning Partners held 374 positions worth $2.34B, down 7.1% from $2.52B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Avantax Planning Partners deployed $147M of net new capital in Q2 2022, opening 15 new positions and adding to 155 existing holdings. Its largest new stake was iShares International Select Dividend ETF: 175,773 shares worth $4.77M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Schwab US Large-Cap Value ETF, an estimated $39.3M trimmed.

  • Avantax Planning Partners's largest Q2 2022 buy was iShares International Select Dividend ETF: 175,773 shares worth $4.77M.
  • Avantax Planning Partners added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $44.2M increase.
  • Avantax Planning Partners's biggest Q2 2022 reduction was Schwab US Large-Cap Value ETF, cutting an estimated $39.3M.
  • Avantax Planning Partners fully exited Packaging Corp of America in Q2 2022, selling an estimated $557K.
  • Avantax Planning Partners's ten largest holdings make up 63% of its $2.34B portfolio in Q2 2022.
  • Avantax Planning Partners opened 15 new positions and closed 31 in Q2 2022.
  • Avantax Planning Partners's portfolio value fell 7.1% quarter-over-quarter to $2.34B.

Based on Avantax Planning Partners's 13F filing for Q2 2022, filed 18 Jul 2022.